Latest stories on VALN
Valneva Reports Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate
TipRanks74 · bullishproduct/pr
Why is Valneva stock climbing today?
Investing.com Markets62 · neutralgeneral
Why is Valneva stock rallying today?
Investing.com Markets64 · neutralgeneral
Valneva Announces November 24 Release of Nine-Month 2026 Results
TipRanks50 · neutralgeneral
Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026
Business Insider50 · neutralgeneral
Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026
GlobeNewswire50 · neutralgeneral
Declaration of shares and voting rights Status as of October 31, 2026
GlobeNewswire50 · neutralgeneral
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
GlobeNewswire52 · neutralproduct/pr
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Business Insider52 · neutralproduct/pr
At a glance: stocks gapping down premarket
Seeking Alpha38 · neutralgeneral
Valneva Shares Fall as UK Withdraws Approval for Ixchiq Chikungunya Vaccine
InvestorsHub38 · neutralgeneral
Why is Valneva stock falling today?
Investing.com Markets38 · neutralgeneral
Valneva stock falls after UK revokes Ixchiq vaccine approval
Investing.com Markets32 · bearishgeneral
Valneva falls as UK revokes marketing authorization for chikungunya vaccine
Seeking Alpha28 · bearishgeneral
VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback
Stocktwits News32 · bearishgeneral
Why is Valneva stock sliding today?
Investing.com Markets42 · neutralgeneral
Why is Valneva stock gaining today?
Investing.com Markets50 · neutralgeneral
Valneva announces Ixchiq marketing authorization revoked by UK MHRA
The Fly28 · bearishgeneral
Valneva Says Ixchiq Vaccine Recalled in U.K. Due to Safety Concerns
MarketWatch22 · bearishproduct/pr
Valneva Provides Update on IXCHIQ® in the United Kingdom
Business Insider50 · neutralgeneral
Declaration of shares and voting rights - Status as of September 30, 2026
GlobeNewswire50 · neutralgeneral
Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
Yahoo Finance56 · neutralproduct/pr
Declaration of shares and voting rights - Status as of August 31, 2026
GlobeNewswire50 · neutralgeneral
Valneva (VALN) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Valneva: The Lyme Royalty Transition Changes The Earnings Model
Seeking Alpha58 · neutralproduct/pr